NO992916L - Fosfodiesterase 8A - Google Patents

Fosfodiesterase 8A

Info

Publication number
NO992916L
NO992916L NO992916A NO992916A NO992916L NO 992916 L NO992916 L NO 992916L NO 992916 A NO992916 A NO 992916A NO 992916 A NO992916 A NO 992916A NO 992916 L NO992916 L NO 992916L
Authority
NO
Norway
Prior art keywords
polypeptides
polynucleotides
pde8
expression constructs
phosphodiesterase
Prior art date
Application number
NO992916A
Other languages
English (en)
Norwegian (no)
Other versions
NO992916D0 (no
Inventor
Kate Loughney
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25491965&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO992916(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Icos Corp filed Critical Icos Corp
Publication of NO992916D0 publication Critical patent/NO992916D0/no
Publication of NO992916L publication Critical patent/NO992916L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Cereal-Derived Products (AREA)
NO992916A 1997-10-16 1999-06-15 Fosfodiesterase 8A NO992916L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/951,648 US5932465A (en) 1997-10-16 1997-10-16 Phosphodiesterase 8A
PCT/US1998/021956 WO1999019495A1 (en) 1997-10-16 1998-10-16 Phosphodiesterase 8a

Publications (2)

Publication Number Publication Date
NO992916D0 NO992916D0 (no) 1999-06-15
NO992916L true NO992916L (no) 1999-08-06

Family

ID=25491965

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992916A NO992916L (no) 1997-10-16 1999-06-15 Fosfodiesterase 8A

Country Status (14)

Country Link
US (4) US5932465A (de)
EP (2) EP0944725B1 (de)
JP (1) JP2001512327A (de)
CN (2) CN1229499C (de)
AT (1) ATE295423T1 (de)
AU (1) AU1097499A (de)
BR (1) BR9806318A (de)
CA (1) CA2275135A1 (de)
DE (1) DE69830143T2 (de)
ES (1) ES2245485T3 (de)
IL (3) IL130287A0 (de)
NO (1) NO992916L (de)
RU (2) RU2272841C2 (de)
WO (1) WO1999019495A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2238283C (en) 1997-05-30 2002-08-20 Cell Pathways, Inc. Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions
US5858694A (en) * 1997-05-30 1999-01-12 Cell Pathways, Inc. Method for identifying compounds for inhibition of cancerous lesions
EP0967284A1 (de) * 1998-05-28 1999-12-29 Pfizer Limited Phosphodiesterasen
US6130053A (en) * 1999-08-03 2000-10-10 Cell Pathways, Inc. Method for selecting compounds for inhibition of neoplastic lesions
GB9922125D0 (en) 1999-09-17 1999-11-17 Pfizer Ltd Phosphodiesterase enzymes
US6673564B2 (en) * 1999-10-18 2004-01-06 Millennium Pharmaceuticals, Inc. Methods for using 22045, a human cyclic nucleotide phosphodiesterase
CN1297049A (zh) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人环磷酸鸟嘌呤抑制的磷酸二酯酶17和编码这种多肽的多核苷酸
US6555547B1 (en) 2000-02-28 2003-04-29 Cell Pathways, Inc. Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative
US6569638B1 (en) 2000-03-03 2003-05-27 Cell Pathways, Inc Method for screening compounds for the treatment of neoplasia
CN1312381A (zh) * 2000-03-07 2001-09-12 上海博德基因开发有限公司 一种新的多肽——人环腺苷酸磷酸二脂酶13和编码这种多肽的多核苷酸
US7138259B2 (en) * 2000-09-12 2006-11-21 University Of Washington PDEs and uses thereof
CN100344646C (zh) * 2001-07-10 2007-10-24 奥林格斯技术有限公司 含有寡核苷酸的药物组合物及其用途
WO2004042388A2 (en) * 2002-11-08 2004-05-21 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a)
US7700095B2 (en) 2004-03-19 2010-04-20 Yale University Detection, isolation and uses of renalase (monoamine oxidase c)
EP1940389A2 (de) 2005-10-21 2008-07-09 Braincells, Inc. Modulation von neurogenese durch pde-hemmung
JP2009516693A (ja) 2005-11-21 2009-04-23 イエール ユニバーシティ レナラーゼ（モノアミンオキシダーゼｃ）の調節方法
US20080260643A1 (en) * 2007-03-27 2008-10-23 Omeros Corporation Use of pde7 inhibitors for the treatment of movement disorders
RU2651474C2 (ru) * 2009-05-12 2018-04-19 Конинклейке Филипс Электроникс Н.В. Фосфодиэстераза 4d7 как маркер рака предстательной железы
RU2601154C2 (ru) * 2011-03-11 2016-10-27 Синаджива Байофарма Корп Гибридные белки npp1
RU2760943C2 (ru) * 2011-09-15 2021-12-01 Алексион Фармасьютикалз, Инк. Гибридные белки NPP1
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69034135T3 (de) * 1989-12-22 2012-08-23 Laboratoires Serono S.A. DNS-Konstrukten zur Aktivierung und Veränderung der Expression von endogenen Genen
AU664847B2 (en) * 1991-05-15 1995-12-07 Cell Genesys, Inc. Genomic modifications with homologous DNA targeting
TW402639B (en) * 1992-12-03 2000-08-21 Transkaryotic Therapies Inc Protein production and protein delivery
US5798246A (en) * 1996-03-25 1998-08-25 Incyte Pharmaceuticals, Inc. Cyclic nucleotide phosphodiesterase

Also Published As

Publication number Publication date
CN1800399A (zh) 2006-07-12
EP1571216A2 (de) 2005-09-07
CN1248291A (zh) 2000-03-22
DE69830143T2 (de) 2006-03-02
US6566087B1 (en) 2003-05-20
EP0944725B1 (de) 2005-05-11
DE69830143D1 (en) 2005-06-16
ATE295423T1 (de) 2005-05-15
IL175698A0 (en) 2008-02-09
IL130287A (en) 2006-08-20
ES2245485T3 (es) 2006-01-01
RU2005136013A (ru) 2007-05-27
WO1999019495A1 (en) 1999-04-22
JP2001512327A (ja) 2001-08-21
CA2275135A1 (en) 1999-04-22
US6133007A (en) 2000-10-17
US20030215919A1 (en) 2003-11-20
BR9806318A (pt) 2000-03-14
RU2272841C2 (ru) 2006-03-27
NO992916D0 (no) 1999-06-15
US5932465A (en) 1999-08-03
EP1571216A3 (de) 2006-04-26
CN1229499C (zh) 2005-11-30
AU1097499A (en) 1999-05-03
IL130287A0 (en) 2000-06-01
EP0944725A1 (de) 1999-09-29

Similar Documents

Publication Publication Date Title
IL175698A0 (en) Phosphodiesterase 8a
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
DE69805237D1 (de) Tumornekrose zugehöriger Rezeptor, TR4
WO2000029574A3 (en) Inflammation-associated genes
WO1999042596A3 (en) Phosphodiesterase 10
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
DE68917556D1 (de) Quinolyloxazol-2-one, nützlich als Proteinkinase-C-Inhibitoren.
WO2001012660A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
WO1998057983A3 (en) Mammalian neuro-growth factor like protein
ID24633A (id) Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya
WO1999033870A3 (en) Human regulatory proteins
WO2001002563A3 (en) HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS
NO990666D0 (no) FremgangsmÕte for diversitets-kombinering, samt mottaker
WO2001007471A3 (en) Cell cycle and proliferation proteins
NO985002D0 (no) FremgangsmÕte for mottaking, samt mottaker
WO2000021986A3 (en) Matrix-remodeling genes
WO1999009182A3 (en) Rab proteins
WO2000040722A3 (en) Insulin-synthesis genes
ATE234302T1 (de) Di- oder triazaspiro(4,5)decanderivate
WO2000060082A3 (en) Vesicle associated proteins
WO2001004297A3 (en) Human proteins having hydrophobic domains and dnas encoding these proteins
WO1998057986A3 (en) Human preprotachykinin b
WO1999029720A3 (en) Mammalian alpha helical protein-1
WO2000071679A3 (en) Human oxidoreductase proteins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application